ECEIM consensus statement on equine metabolic syndrome - PubMed (original) (raw)

ECEIM consensus statement on equine metabolic syndrome

Andy E Durham et al. J Vet Intern Med. 2019 Mar.

Abstract

Equine metabolic syndrome (EMS) is a widely recognized collection of risk factors for endocrinopathic laminitis. The most important of these risk factors is insulin dysregulation (ID). Clinicians and horse owners must recognize the presence of these risk factors so that they can be targeted and controlled to reduce the risk of laminitis attacks. Diagnosis of EMS is based partly on the horse's history and clinical examination findings, and partly on laboratory testing. Several choices of test exist which examine different facets of ID and other related metabolic disturbances. EMS is controlled mainly by dietary strategies and exercise programs that aim to improve insulin regulation and decrease obesity where present. In some cases, pharmacologic aids might be useful. Management of an EMS case is a long-term strategy requiring diligence and discipline by the horse's carer and support and guidance from their veterinarians.

Keywords: EMS; endocrinopathic; insulin; laminitis.

© 2019 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine.

PubMed Disclaimer

Conflict of interest statement

The authors provide the following declarations:

A.E. Durham is employed by the Liphook Equine Hospital that offers a commercial diagnostic service including endocrine testing of horses and has received travel expenses from Boehringer Ingelheim Vetmedica for meetings related to Equine Metabolic Syndrome.

N. Frank has received financial compensation for consultation on study design for Boehringer‐Ingelheim Vetmedica, Inc. and Kindred Biosciences, Inc. Boehringer‐Ingelheim Vetmedica, Inc. has also supported travel and accommodation expenses for Equine Endocrinology Group meetings.

C.M. McGowan is employed by the University of Liverpool which has received funding for research projects and consultancy related to Equine Metabolic Syndrome from Boehringer Ingelheim Vetmedica.

K. Feige is employed by the University of Veterinary Medicine, Hannover which has received funding for research grants related to Equine Metabolic Syndrome from Boehringer Ingelheim Vetmedica.

K. Fey is employed by the Justus‐Liebig‐University in Giessen/Germany and has received fees for consultancy, presentations as well as travel expenses from Boehringer Ingelheim Vetmedica for subjects related to equine endocrine diseases.

Figures

Figure 1

Figure 1

The interrelated components of insulin dysregulation

Comment in

Similar articles

Cited by

References

    1. Coffman JR, Colles CM. Insulin tolerance in laminitic ponies. Can J Comp Med. 1983;47(3):347‐351. - PMC - PubMed
    1. Jeffcott LB, Field JR, McLean JG, O'Dea K. Glucose tolerance and insulin sensitivity in ponies and Standardbred horses. Equine Vet J. 1986;18(2):97‐101. - PubMed
    1. Johnson PJ. The equine metabolic syndrome peripheral Cushing's syndrome. Vet Clin North Am Equine Pract. 2002;18(2):271‐293. - PubMed
    1. Frank N, Geor RJ, Bailey SR, Durham AE, Johnson PJ, American College of Veterinary Internal Medicine . Equine metabolic syndrome. J Vet Intern Med. 2010;24(3):467‐475. - PubMed
    1. Frank N, Tadros EM. Insulin dysregulation. Equine Vet J. 2014;46(1):103‐112. - PubMed

MeSH terms

Substances

LinkOut - more resources